We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLDE:NASDAQSlide Insurance Holdings, Inc. Analysis

Data as of 2026-05-01 - not real-time

$18.65

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Slide Insurance is trading well above its short‑term moving averages, indicating a bullish price momentum, while the RSI sits comfortably in the middle of its range, suggesting no immediate overbought pressure. Fundamentally, the company boasts a low price‑to‑earnings multiple far beneath the industry average and a remarkably high return on equity, underscoring strong profitability. Cash reserves are ample relative to a modest debt load, and the recent completion of a $120 million share repurchase followed by authorization of an additional $125 million buyback signals confidence from management. Volume trends are upward, supporting the price advance, and the market sentiment index reflects extreme greed, aligning with analyst upside expectations. Recent earnings showed revenue flat year‑over‑year but a solid increase in net income, and the board’s aggressive capital return program provides an additional catalyst. Overall, the combination of value‑oriented pricing, robust profitability metrics, and supportive technical signals makes SLDE an attractive candidate for investors seeking upside with limited downside risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Bullish price momentum above key moving averages
  • Aggressive share repurchase program adding buy‑side pressure
  • Increasing trading volume confirming demand

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained low valuation relative to peers
  • Strong cash position and low leverage
  • Potential for continued earnings growth as premiums rise

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • High return on equity indicating durable profitability
  • Undervalued pricing offering margin of safety
  • Stable U.S. geographic focus limiting exposure to foreign risks

Key Metrics & Analysis

Financial Health

Revenue Growth38.20%
Profit Margin38.86%
P/E Ratio5.1
ROE59.66%
ROA17.03%
Debt/Equity3.74
P/B Ratio2.1
Industry P/E17.6

Technical Analysis

TrendBullish
RSI53.2
Support$17.21
Resistance$20.17
MA 20$18.46
MA 50$18.17
MA 200$16.88
MACDBearish
VolumeIncreasing
Fear & Greed Index90.91

Valuation

Target Price$25.20
Upside/Downside35.12%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.63
Volatility37.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.